Billings Clinic
Especially For:

Clinical Trials

Title   Leukemia (S1117) : CMML and Myelodysplastic Syndromes
Description   A Randomized Phase II Study of Azacitidine in Combinaiton with Lenalidomide vs. Azacitidine Alone vs. Azacitidine in Combination with Vorinostat for Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
IRB Number   SWOG S1117
Category   Leukemia
Inclusion/Notes   No prior treatment
PS 0-2
Age 18 or older
No peripheral neuropathy > grade 2
Treatment continues until progression
Status   Open
Start Date   06/08/2012
Principal Investigator (PI)   Jorge Nieva, MD
Physician Profile   Hematology/Oncology
Contact Name   Linda Allen, RN
Contact Email   lallen@billingsclinic.org
Phone   (406) 435-7484
Alternate Phone   (406) 435-7480
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.